D49- neoplasms
A clinical study to measure new biomarker and how it relates to weight loss and metabolism in patients with cancer associated cachexia
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Registry summary (technical)
Evaluation of a novel biomarker for cancer associated cachexia with special reference to lipid and carbohydrate metabolism - NIL
Sponsor: NA
CTRI/2025/04/084657 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026